
YiQiFuMai Powder Injection attenuates coronary artery ligation-induced myocardial remodeling and heart failure through modulating MAPKs signaling pathway
Keywords: Ginsenoside Rf (PubChem CID: 441922); Notoginsenoside R2 (PubChem CID: 21599925); Ginsenoside Re (PubChem CID: 73149); Schisandrol A (PubChem CID: 11102092); Ginsenoside Rc (PubChem CID: 100018); Schizandrin B (PubChem CID: 108130); YiQiFuMai powder injec